These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 18451723)

  • 21. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
    Busby M; Donaghy M
    J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
    Kes P; Basić-Kes V; Basić-Jukić N; Demarin V
    Acta Clin Croat; 2012 Mar; 51(1):137-53. PubMed ID: 22920015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
    Bembeeva RT; Zavadenko NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):83-93. PubMed ID: 26356621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Intravenous Immunoglobulin in Neurological Diseases.
    Lünemann JD; Quast I; Dalakas MC
    Neurotherapeutics; 2016 Jan; 13(1):34-46. PubMed ID: 26400261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic apheresis in neurology critical care.
    Natarajan N; Weinstein R
    J Intensive Care Med; 2005; 20(4):212-25. PubMed ID: 16061904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin: striving for appropriate use.
    Kumar A; Teuber SS; Gershwin ME
    Int Arch Allergy Immunol; 2006; 140(3):185-98. PubMed ID: 16682800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurologic indications for therapeutic plasma exchange: 2013 update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2014 Aug; 29(4):211-9. PubMed ID: 24890467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy for autoimmune autonomic ganglionopathy.
    Iodice V; Kimpinski K; Vernino S; Sandroni P; Low PA
    Auton Neurosci; 2009 Mar; 146(1-2):22-5. PubMed ID: 19056323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune disorders affecting both the central and peripheral nervous system.
    Kamm C; Zettl UK
    Autoimmun Rev; 2012 Jan; 11(3):196-202. PubMed ID: 21619947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
    Soueidan SA; Dalakas MC
    Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic steadily progressive central and peripheral predominantly motor demyelination, involving the cranial nerves, responsive to immunoglobulins.
    Bentes C; de Carvalho M; de Sá J; Luís ML
    Electromyogr Clin Neurophysiol; 1999; 39(1):33-7. PubMed ID: 10076759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases.
    Yücesan C; Arslan O; Arat M; Yücemen N; Ayyildiz E; Ilhan O; Mutluer N
    Transfus Apher Sci; 2007 Feb; 36(1):103-7. PubMed ID: 17224307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eighty three years of the Guillain-Barré syndrome: clinical and immunopathologic aspects, current and future treatments.
    Toyka KV
    Rev Neurol (Paris); 1999 Oct; 155(10):849-56. PubMed ID: 10546299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials.
    Sørensen PS
    Neurol Sci; 2003 Oct; 24 Suppl 4():S227-30. PubMed ID: 14598048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders.
    Lehmann HC; Hartung HP; Hetzel GR; Stüve O; Kieseier BC
    Arch Neurol; 2006 Jul; 63(7):930-5. PubMed ID: 16831960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
    Korsak J
    Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review: the use of rituximab in neuromuscular diseases.
    Ibrahim H; Dimachkie MM; Shaibani A
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):91-102. PubMed ID: 21386778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous immunoglobulin use for neurologic diseases.
    Koski CL; Patterson JV
    J Infus Nurs; 2006; 29(3 Suppl):S21-8. PubMed ID: 16878852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plasmapheresis for Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Odaka M
    Nihon Rinsho; 2004 May; 62 Suppl 5():491-5. PubMed ID: 15197970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.